By: Linda Flegge
Cardio Diagnostics (NASDAQ:CDIO – Get Free Report) and Genmab A/S (NASDAQ:GMAB – Get Free Report) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, institutional ownership, valuation, analyst recommendations, risk, profitability and earnings. Institutional & Insider Ownership 8.1% of Cardio Diagnostics […]